Stock Fundamentals

Company Information

Company Name
Medpace Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US58506Q1094
CIK: 0001668397
CUSIP: 58506Q109
Currency: USD
Full Time Employees: 6,300
Phone: 513 579 9911
Fiscal Year End: December
IPO Date: Aug 11, 2016
Description:

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Address:

5375 Medpace Way, Cincinnati, OH, United States, 45227

Directors & Officers

Name Title Year Born
Dr. August James Troendle M.D. CEO, President & Chairman 1956
Mr. Kevin M. Brady CFO & Treasurer 1975
Mr. Stephen P. Ewald J.D. Chief Compliance Officer, General Counsel & Corporate Secretary 1969
Mr. Brad W. Hansman Executive Vice President of Operations 1983
Ms. Lauren Morris Associate Director of Investors Relations NA
Mr. Todd Meyers Vice President of Business Development & Marketing NA
Mr. Weimin Gai MS Senior Vice President of Biometrics NA
Mr. John T. Wynne MBA Chief Business Officer NA
Ms. Reinilde Heyrman M.D. Chief Medical Officer of Medical Department 1961
Ms. Gina Leisring M.P.H. Senior Vice President of Clinical Monitoring NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2026 Jesse J Geiger N/A Sale 31.71K $455.30 $14.44M
Feb 26, 2026 David Taylor N/A Purchase N/A $447.09 N/A
Jan 29, 2026 David Taylor N/A Purchase N/A $593.07 N/A
Jan 16, 2026 David Taylor N/A Sale N/A $610.90 N/A
Jan 15, 2026 Gilbert Ray Cisneros, Jr. N/A Sale N/A $618.04 N/A
Dec 03, 2025 August J Troendle N/A Sale 668.00 $590.69 $394.58K
Dec 01, 2025 August J Troendle N/A Sale 23.18K $593.25 $13.75M
Nov 28, 2025 August J Troendle N/A Sale 15.15K $593.46 $8.99M
Nov 26, 2025 August J Troendle N/A Sale 41.33K $606.88 $25.08M
Nov 25, 2025 August J Troendle N/A Sale 42.39K $615.52 $26.09M
Nov 24, 2025 Susan E Burwig N/A Sale 20.00K $609.15 $12.18M
Nov 24, 2025 August J Troendle N/A Sale 59.03K $607.78 $35.87M
Nov 21, 2025 August J Troendle N/A Sale 21.86K $592.18 $12.94M
Nov 21, 2025 Kevin M Brady N/A Sale 3.00K $590.35 $1.77M
Nov 20, 2025 August J Troendle N/A Sale 6.83K $598.49 $4.09M
Nov 19, 2025 August J Troendle N/A Sale 23.86K $592.07 $14.13M
Nov 18, 2025 August J Troendle N/A Sale 7.19K $590.84 $4.25M
Nov 17, 2025 August J Troendle N/A Sale 6.05K $591.00 $3.57M
Nov 14, 2025 August J Troendle N/A Sale 14.75K $595.26 $8.78M
Nov 14, 2025 Robert O Kraft N/A Sale 6.47K $591.85 $3.83M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.47M Mar 31, 2026 8.65% $0.02 2.40%
Vanguard Group Inc 2.26M Dec 31, 2025 7.92% $0.02 -0.93%
AQR Capital Management LLC 1.35M Mar 31, 2026 4.74% $0.29 0.31%
Vanguard Portfolio Management, LLC 1.12M Mar 31, 2026 3.93% $0.03 0.00%
Vanguard Capital Management, LLC 1.01M Mar 31, 2026 3.54% $0.01 0.00%
Wasatch Advisors LP 773.93K Mar 31, 2026 2.71% $2.47 19.38%
Geode Capital Management, LLC 745.11K Mar 31, 2026 2.61% $0.02 11.66%
State Street Corp 682.23K Mar 31, 2026 2.39% $0.01 2.61%
Amvescap Plc. 577.57K Mar 31, 2026 2.02% $0.04 19.67%
Renaissance Technologies Corp 504.67K Mar 31, 2026 1.77% $0.38 8.32%
Baillie Gifford & Co Limited. 503.19K Mar 31, 2026 1.76% $0.25 -8.02%
Mawer Investment Management Ltd 446.10K Mar 31, 2026 1.56% $1.39 9.53%
D. E. Shaw & Co LP 432.60K Mar 31, 2026 1.51% $0.12 -18.10%
Arrowstreet Capital Limited Partnership 395.77K Mar 31, 2026 1.39% $0.10 5.53%
Dimensional Fund Advisors, Inc. 348.49K Mar 31, 2026 1.22% $0.03 -3.02%
UBS Group AG 340.43K Mar 31, 2026 1.19% $0.02 3.51%
T. Rowe Price Associates, Inc. 289.51K Mar 31, 2026 1.01% $0.02 148.33%
Morgan Stanley - Brokerage Accounts 288.42K Mar 31, 2026 1.01% $0.01 -30.78%
Bessemer Group Inc 285.43K Mar 31, 2026 1.00% $0.22 -9.97%
Madison Asset Management, LLC 262.29K Mar 31, 2026 0.92% $1.56 -5.57%

Shares Statistics

Shares Outstanding: 28.56M
Shares Float: 23.00M
% Insiders: 1,942.70%
% Institutions: 8,816.80%
Short % Float: 9.06%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 760.67K 2.66% ▲ 0.02% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 722.89K 2.53% ▲ 0.64% Apr 30, 2026
3 Vanguard Small Cap Index 523.12K 1.83% ▼ 0.22% Apr 30, 2026
4 Invesco S&P MidCap Quality ETF 313.60K 1.10% ▲ 0.00% May 29, 2026
5 Vanguard Small Cap Growth Index Inv 293.69K 1.03% ▲ 0.04% Apr 30, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 253.18K 0.89% ▲ 1.07% Apr 30, 2026
7 Vanguard Explorer Inv 213.35K 0.75% ▲ 0.99% Mar 31, 2026
8 State Street® SPDR® S&P MIDCAP 400® ETF 169.63K 0.59% ▲ 0.38% Apr 30, 2026
9 iShares Biotechnology ETF 168.11K 0.59% ▲ 1.47% May 29, 2026
10 Wasatch Core Growth 161.30K 0.56% ▼ 5.16% Mar 31, 2026

Valuation Metrics

Enterprise Value: $14.76B
Trailing P/E: 33.68
Forward P/E: 31.85

Financial Highlights

Market Cap: $15.29B
EBITDA: $591.01M
P/E Ratio: $33.68
PEG Ratio: $3.29
Book Value: $20.95
Earnings/Share: $15.90
Profit Margin: 17.19%
Operating Margin: 20.03%
ROA (TTM): 17.47%
ROE (TTM): 77.25%
Revenue (TTM): $2.68B
Revenue/Share (TTM): $94.44
Earnings Growth (YOY): 16.60%
Revenue Growth (YOY): 26.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.74x 0.05x 0.77x N/A 0.04x
2024-12-31 0.93x 0.03x 0.61x 17.88x 0.05x
2023-12-31 0.64x 0.52x 0.66x 690.22x 0.81x
2022-12-31 0.42x 0.13x 0.71x 95.94x 0.16x
2021-12-31 1.24x 0.17x 0.43x 1,891.57x 0.71x
2020-12-31 1.08x 0.17x 0.42x 544.11x 0.72x
2019-12-31 0.92x 0.15x 0.36x 81.16x 0.73x
2018-12-31 0.69x 0.28x 0.39x 12.39x 1.20x
2017-12-31 0.67x 0.44x 0.47x 8.58x 2.00x
2016-12-31 0.79x 0.27x 0.38x 2.71x 1.65x
2015-12-31 0.71x 1.04x 0.58x 0.75x 4.81x
2014-12-31 1.00x 1.27x 0.63x 0.98x 5.44x
2013-12-31 N/A N/A N/A 3.27x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MEDP.US!